Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 731,249 |
|
|||||
| News | - | ||||||
| Day High | 3.75 | Low High |
|||||
| Day Low | 3.40 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Sutro Biopharma Inc | STRO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.17 | -4.57% | 3.55 | 19:51:39 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.72 | 3.40 | 3.75 | 3.47 | 3.72 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,476 | 731,249 | $ 3.53 | $ 2,584,211 | - | 2.005 - 6.13 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:51:39 | formt | 200 | $ 3.55 | USD |
Sutro Biopharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 211.51M | 60.95M | - | 153.73M | -106.79M | -1.75 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sutro Biopharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical STRO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.94 | 4.03 | 3.40 | 3.74 | 648,666 | -0.39 | -9.90% |
| 1 Month | 4.26 | 6.13 | 3.40 | 4.75 | 1,331,185 | -0.71 | -16.67% |
| 3 Months | 4.71 | 6.13 | 3.20 | 4.55 | 1,029,374 | -1.16 | -24.63% |
| 6 Months | 3.05 | 6.13 | 2.005 | 3.97 | 951,777 | 0.50 | 16.39% |
| 1 Year | 4.71 | 6.13 | 2.005 | 4.17 | 696,267 | -1.16 | -24.63% |
| 3 Years | 20.41 | 23.70 | 2.005 | 7.17 | 558,672 | -16.86 | -82.61% |
| 5 Years | 10.00 | 28.30 | 2.005 | 9.32 | 422,380 | -6.45 | -64.50% |
Sutro Biopharma Description
| Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. |
